Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.06. | Clinical Laserthermia Systems AB: Communique from the Annual General Meeting on Friday June 27th in Clinical Laserthermia Systems A | 3 | Cision News | ||
06.06. | Clinical Laserthermia Systems publishes annual report for 2024 | 2 | Cision News | ||
27.05. | Clinical Laserthermia Systems AB: Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 27, 2025 | 1 | Cision News | ||
16.05. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Interim report for January - March 2025 | 134 | GlobeNewswire (Europe) | Summary of the interim report (relates to the Group)Three months (01/01/2025-03/31/2025)
Net sales totaled SEK 4,496,000 (SEK 3,140,000).
Operating profit totaled SEK -7,868,000 (SEK -16,992,000).
Profit/loss... ► Artikel lesen | |
CLINICAL LASERTHERMIA SYSTEMS Aktie jetzt für 0€ handeln | |||||
28.04. | ClearPoint Neuro, Inc.: ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism to Include 1.5 T MRI | 113 | ACCESS Newswire | SOLANA BEACH, CA / ACCESS Newswire / April 28, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the... ► Artikel lesen | |
28.04. | Clinical Laserthermia Systems, together with its partner ClearPoint Neuro, announces FDA submission to expand the labeling of ClearPoint Prism® to include 1.5 T MRI guidance | 3 | Cision News | ||
15.04. | Clinical Laserthermia Systems AB: Updated clinical guidelines provide clear recommendations on the use of Laser Interstitial Thermal Therapy (LITT) in patients with metastatic brain tumors and radiation necrosis | 111 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (publ) ("CLS or the "Company") today announces that updated clinical guidelines with recommendations supporting the use of Laser Interstitial Thermal Therapy (LITT)... ► Artikel lesen | |
08.04. | Clinical Laserthermia Systems AB: Proposed U.S. tariffs expected to have minimal impact on CLS business | 118 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") clarifies that the proposed U.S. tariffs are expected to have minimal impact on its total business, including operations... ► Artikel lesen | |
27.02. | Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion | 1 | Cision News | ||
21.02. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2024 | 191 | GlobeNewswire (Europe) | Summary of the year-end report (relates to the Group)Full year (01/01/2024-12/31/2024)
Net sales totaled SEK 18,783,000 (SEK 8,273,000).
Operating profit/loss totaled SEK -54,254,000 (SEK -65,933... ► Artikel lesen | |
07.02. | Clinical Laserthermia Systems AB: CLS co-founder and former CEO Lars-Erik Eriksson leaves the board of directors at his own request | 1.128 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that Lars-Erik Eriksson, co-founder, long-time board member and former CEO, is leaving the board of directors... ► Artikel lesen | |
30.01. | Clinical Laserthermia Systems AB: Data from the clinical trial using MRI-guided FLA with TRANBERG® Thermal Therapy System in patients with prostate cancer at Radboud University Medical Center (Nijmegen, NL) is now published | 1 | Cision News | ||
14.01. | Clinical Laserthermia Systems AB: CLS Recaps 2024 and Provides Outlook for 2025-26 | 511 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that, in its recap of 2024, in the first nine months of 2024 compared to the same period 2023, CLS saw... ► Artikel lesen | |
23.10.24 | Clinical Laserthermia Systems AB: CLS focus entirely on its successful neurosurgery business positioning the company for sustainable high-margin growth with a more streamlined operation | 206 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces it will focus entirely on its successful neurosurgery business to drive sustainable high-margin growth... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 40,890 | -0,87 % | Aktie von Fresenius SE & Co. KGaA heute am Aktienmarkt kaum gefragt: Kurs fällt (41,21 €) | An der deutschen Börse notiert die Fresenius SE & Co. KGaA-Aktie derzeit ein wenig leichter. Die Aktie notiert zur Stunde bei 41,21 Euro. Der Anteilsschein von Fresenius+Co KgaA verzeichnet aktuell... ► Artikel lesen | |
CARL ZEISS MEDITEC | 51,70 | +1,47 % | DEUTSCHE BANK RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Carl Zeiss Meditec vor der Quartalsbilanz mit einem Kursziel von 55 Euro auf "Hold" belassen. Der Medizintechnikhersteller... ► Artikel lesen | |
DRAEGERWERK | 70,10 | +2,49 % | DAX leidet unter EU-Zöllen - BASF, Brenntag, Commerzbank, Drägerwerk, Mutares, Renk, Thyssenkrupp ... | Der DAX hat nach dem Ausbruch auf ein neues Rekordhoch nicht mehr zulegen können und am vergangenen Freitag rund 200 Zähler eingebüßt. Nachdem Donald Trump seine Zolldrohungen gegenüber Europa erneuert... ► Artikel lesen | |
MEDTRONIC | 77,05 | -0,09 % | Medtronic Begins U.S. Trial Of Onyx LES For Peripheral Arterial Hemorrhage | DUBLIN (dpa-AFX) - Medtronic (MDT) has announced the enrollment of the first patient in its PELE (PEripheral Onyx Liquid Embolic) clinical trial, which will evaluate the safety and efficacy... ► Artikel lesen | |
INTUITIVE SURGICAL | 444,50 | -0,37 % | Intuitive Surgical, Inc.: Intuitive demonstrates telesurgery capabilities | SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has today demonstrated... ► Artikel lesen | |
TELADOC HEALTH | 6,912 | -0,27 % | Teladoc launches Wellbound, an employee assistance program that leverages BetterHelp | ||
THERMO FISHER | 355,20 | -0,43 % | Thermo Fisher übernimmt Sterilproduktion von Sanofi in den USA | Der US-Laborausrüster Thermo Fisher Scientific erweitert seine Produktionsinfrastruktur und übernimmt die Sterilfabrik von Sanofi im US-Bundesstaat New Jersey. Das Werk in Ridgefield soll künftig das... ► Artikel lesen | |
ROKU | 80,20 | -0,09 % | Roku Set For Q2 Spotlight As Ad Resilience, Frndly Boost, Amazon Deal Fuel Investor Optimism | ||
HIMS & HERS HEALTH | 43,220 | -0,25 % | Hims & Hers nach Aus mit Novo Nordisk: "Erhöhtes Risiko von Rechtsstreitigkeiten" | Wie gewonnen, so zerronnen: Zunächst entfachte die umfangreiche Zusammenarbeit zwischen dem Telehealth-Unternehmen Hims & Hers und dem Biopharma-Riesen Novo Nordisk jede Menge Euphorie. Doch dann kam... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,108 | +4,85 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
DEXCOM | 71,80 | -0,51 % | FDA announces recall of certain Dexcom glucose monitoring devices | ||
ALCON | 75,00 | -0,32 % | Alcon's Unity VCS Gets Health Canada Approval | OTTAWA (dpa-AFX) - Alcon, Inc. (ALC) announced Tuesday that UNITY Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first to be introduced from... ► Artikel lesen | |
RESMED | 220,10 | -0,81 % | Analyst Expectations For ResMed's Future | ||
HEALWELL AI | 0,905 | +0,61 % | HEALWELL AI veröffentlicht Unternehmensupdate: Performancesteigerung im KI-Geschäft, Übernahme der verbleibenden Firmenanteile von Pentavere und stärkere Vernetzung innerhalb des KI-Geschäftssegments | - HEALWELL hat eine Performancesteigerung für sein KI-Kerngeschäftssegment bekannt gegeben. Der vorläufige Umsatz wird für die ersten sechs Monate des Jahres 2025
voraussichtlich mehr... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,110 | -1,03 % | Siemens Healthineers: Die Entscheidung rückt näher | Seit Ende Mai läuft die Siemens Healthineers-Aktie in einer engen Spanne seitwärts. Zuletzt wurde der Kurs durch ein stetes Für und Wider in diesem Käfig gehalten. Aber spätestens mit den näher rückenden... ► Artikel lesen |